FDA Panel To Consider Potential Tumor Risk With Fibrocell Science's Wrinkle Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
The Cellular, Tissue and Gene Therapies Advisory Committee meets Oct. 9 to discuss the first cellular product proposed to treat nasolabial facial wrinkles.